
Thursday, May 15, 2025 5:02:33 PM
You’ve spent years trying to convince everyone this stock is worthless, the future is dead, and no backstops are coming. And yet… here you are. Still. Every day. On this board.
For someone who supposedly believes it’s all a lie, you sure act like you’re afraid it might not be.
You recycle the same tired character assassination like somehow repeating it will make it true. But here’s the inconvenient reality: I’m still standing… and so is ERHC. And while you keep claiming it’s worthless, you refuse to walk away. That’s not skepticism. That’s fear—fear that you might actually be cornered.
And let’s talk about your favorite word—fraud. You throw it around like you understand it, but you clearly don’t. Fraud requires intentional deception of material fact for personal gain. Sharing theories, public filings, and market strategies isn’t fraud—it’s called doing research. If you’re so sure of your legal knowledge, go run that argument by an actual securities attorney. You might accidentally learn something.
Meanwhile, the clock is ticking. While you’re busy screaming into the void, the rest of us are calmly watching the final moves line up.
Keep talking. It won’t stop what’s coming.
—Krombacher
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM